Skip to content

Helen Torley, President and CEO at Halozyme Therapeutics, sold HALO on Sep 9, 2026

Data as of Oct 16

▼ SELL$10.9K100 shares at $108.67Helen Torley President and CEOHALO Halozyme Therapeutics, Inc.
Watch HALO
Traded
Sep 9, 2026
Disclosed
Sep 11, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Helen Torley, President and CEO at Halozyme Therapeutics, sold HALO on Sep 9, 2026TRADEDDISCLOSED
HALOSimilar stocks (XLV — its sector index fund), rebased to HALO's price on the disclosure day
HALO since disclosure
+13.7%
after the sale
Similar stocks (XLV) since disclosure
+6.9%
XLV — its sector index fund

Change in closing price from Sep 11, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$1.7Mdisclosed Sep 11 · filed the same day
  2. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$485Kdisclosed Sep 11 · filed the same day
  3. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$1.6Mdisclosed Sep 11 · filed 1 day after the trade
  4. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$582Kdisclosed Sep 11 · filed 1 day after the trade
  5. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$711Kdisclosed Sep 11 · filed 2 days after the trade
  6. ▼ SELLHelen Torley President and CEOHALO Halozyme Therapeutics, Inc.$1.4Mdisclosed Sep 11 · filed 2 days after the trade

See every trade on HALO →